PATIENT_ID,MED_START,MED_END,MED_NAME
3,4/19/18,4/19/18,carboplatin
101,4/19/18,4/19/18,pembrolizumab
101,5/10/18,5/10/18,pembrolizumab
101,5/29/18,5/29/18,pembrolizumab
101,6/19/18,6/19/18,pembrolizumab
101,7/12/18,7/12/18,pembrolizumab
101,8/2/18,8/2/18,pembrolizumab
101,8/23/18,8/23/18,pembrolizumab
101,9/13/18,9/13/18,pembrolizumab
101,10/4/18,10/4/18,pembrolizumab
101,10/25/18,10/25/18,pembrolizumab
101,11/15/18,11/15/18,pembrolizumab
101,12/6/18,12/6/18,pembrolizumab
101,12/27/18,12/27/18,pembrolizumab
101,1/24/19,1/24/19,pembrolizumab
101,1/24/19,1/24/19,pemetrexed
101,1/24/19,1/24/19,CARBOplatin
101,2/14/19,2/14/19,pembrolizumab
101,2/14/19,2/14/19,pemetrexed
101,2/14/19,2/14/19,CARBOplatin
101,3/7/19,3/7/19,pembrolizumab
101,3/7/19,3/7/19,pemetrexed
101,3/7/19,3/7/19,CARBOplatin
101,3/28/19,3/28/19,pembrolizumab
101,3/28/19,3/28/19,pemetrexed
101,3/28/19,3/28/19,CARBOplatin
101,4/18/19,4/18/19,pembrolizumab
101,4/18/19,4/18/19,pemetrexed
2,1/14/18,1/14/18,nivolumab
2,2/3/18,2/3/18,nivolumab
2,2/18/18,2/18/18,nivolumab
2,3/4/18,3/4/18,nivolumab
2,3/4/18,3/4/18,CARBOplatin
2,3/18/18,3/18/18,nivolumab
2,3/18/18,3/18/18,CARBOplatin
2,4/1/18,4/1/18,CARBOplatin
2,4/1/18,4/1/18,nivolumab
2,4/14/18,4/14/18,nivolumab
2,4/14/18,4/14/18,CARBOplatin
2,4/29/18,4/29/18,nivolumab
2,4/29/18,4/29/18,CARBOplatin
2,5/14/18,5/14/18,cetuximab
2,5/21/18,5/21/18,cetuximab
2,5/28/18,5/28/18,cetuximab
2,6/4/18,6/4/18,cetuximab
2,6/11/18,6/11/18,cetuximab
2,6/18/18,6/18/18,cetuximab
2,11/12/18,11/12/18,durvalumab
2,11/26/18,11/26/18,durvalumab
4,1/1/20,1/1/20,carboplatin
4,1/1/20,1/1/20,pembrolizumab
4,1/1/20,1/1/20,pemetrexed
4,2/1/20,2/1/20,carboplatin
4,2/1/20,2/1/20,pembrolizumab
4,2/1/20,2/1/20,pemetrexed
4,3/1/20,3/1/20,pembrolizumab
4,3/1/20,3/1/20,pemetrexed
4,4/1/20,4/1/20,pembrolizumab
4,4/1/20,4/1/20,pemetrexed
4,5/1/20,5/1/20,pembrolizumab
4,5/1/20,5/1/20,pembrolizumab
1111,1/1/19,1/1/19,pembrolizumab
1111,2/1/19,2/1/19,pembrolizumab
1111,7/1/19,7/1/19,pembrolizumab
1111,8/1/19,8/1/19,pembrolizumab
1111,9/1/19,9/1/19,pembrolizumab
1111,10/1/19,10/1/19,cisplatin
1111,10/1/19,10/1/19,pemetrexed
1111,11/4/19,11/4/19,cisplatin
1111,11/8/19,11/8/19,pemetrexed
1111,5/2/20,5/2/20,cisplatin
1111,5/16/20,5/16/20,pemetrexed
2222,1/1/19,1/1/19,nivolumab
2222,1/1/19,1/1/19,cisplatin
2222,2/1/19,2/1/19,nivolumab
2222,7/1/19,7/1/19,nivolumab
2222,8/1/19,8/1/19,nivolumab
2222,9/1/19,9/1/19,nivolumab
2222,10/1/19,10/1/19,nivolumab
2222,1/1/20,1/1/20,pembrolizumab
2222,1/1/20,1/1/20,pemetrexed
2222,1/1/20,1/1/20,carboplatin
2222,2/1/20,2/1/20,pembrolizumab
2222,7/1/20,7/1/20,pembrolizumab
2222,8/1/20,8/1/20,pembrolizumab
2222,9/1/20,9/1/20,pembrolizumab
2222,10/1/20,10/1/20,pembrolizumab
3333,1/1/20,1/1/20,pembrolizumab
3333,1/1/20,1/1/20,pemetrexed
3333,2/2/20,2/2/20,pemetrexed
3333,2/1/20,2/1/20,pembrolizumab
3333,3/2/20,3/2/20,pemetrexed
3333,4/15/20,4/15/20,pemetrexed
3333,5/8/20,5/8/20,pemetrexed
3344,1/1/20,1/1/20,pembrolizumab
3344,1/1/20,1/1/20,carboplatin
3344,1/1/20,1/1/20,pemetrexed
3344,2/2/20,2/2/20,pemetrexed
3344,2/2/20,2/2/20,carboplatin
3344,2/1/20,2/1/20,pembrolizumab
3344,3/2/20,3/2/20,pemetrexed
3344,4/15/20,4/15/20,pemetrexed
3344,5/8/20,5/8/20,pemetrexed
4444,1/1/20,1/1/20,pembrolizumab
4444,2/2/20,2/2/20,pembrolizumab
4444,2/1/20,2/1/20,pembrolizumab
4444,3/2/20,3/2/20,pemetrexed
4444,4/15/20,4/15/20,pemetrexed
4444,5/8/20,5/8/20,pemetrexed
5555,1/1/20,1/1/20,erlotinib
5555,2/2/20,2/2/20,erlotinib
5555,3/2/20,3/2/20,erlotinib
5555,10/10/20,10/10/20,erlotinib
5555,11/10/20,11/10/20,erlotinib
5555,5/15/21,5/15/21,erlotinib
6666,10/1/19,10/1/19,cisplatin
6666,10/1/19,10/1/19,pemetrexed
6666,11/4/19,11/4/19,cisplatin
6666,11/8/19,11/8/19,pemetrexed
6666,5/2/20,5/2/20,carboplatin
6666,5/16/20,5/16/20,pemetrexed